Vascular CT Assessment of Structural Autograft and Allograft Healing
2 other identifiers
observational
8
1 country
1
Brief Summary
The purpose of this study is to determine the ability of a cone beam CT to measure bone healing.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for all trials
Started Nov 2006
Longer than P75 for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
November 1, 2006
CompletedFirst Submitted
Initial submission to the registry
January 7, 2008
CompletedFirst Posted
Study publicly available on registry
January 16, 2008
CompletedPrimary Completion
Last participant's last visit for primary outcome
December 1, 2015
CompletedStudy Completion
Last participant's last visit for all outcomes
December 1, 2015
CompletedFebruary 9, 2016
February 1, 2016
9.1 years
January 7, 2008
February 8, 2016
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Change in intramedullary vascular volume and new bone growth based on CBCT
2, 8 & 18 months
Study Arms (1)
1
Patients who have received a structrual allograft or vascularized fibular autograft surgery to reconstruct their tibia, femur, ulna/radius or humerus for treatment of a bone tumor.
Interventions
The Cone Beam Computerized Tomographic (CBCT) device utilizes computerized tomographic technology, a special digital imaging plate and a computer to create a three-dimensional image. The special imaging plate and software allow for small details to be imaged without tissue overlap.
Eligibility Criteria
Patients are recruited from the general practice of 3 of our investigators. Patients will have received an structural allograft or vascularized autograft for the treatment of bone cancer.
You may qualify if:
- male or female
- all races will be included
- autograft or allograft of long bone as part of treatment for bone tumor
You may not qualify if:
- pregnancy
- patients with a history of IV contrast reactions
- contraindication to use of epinephrine or diphenhydramine
- hypertyroidism or history of sensitivity to iodine
- kidney disease (abnormal urinalysis or calculaged GFR) or poor hydration due to poor intake or other causes
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
University of Rochester
Rochester, New York, 14642, United States
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Edward Schwarz, PhD
University of Rochester
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- PROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Professor
Study Record Dates
First Submitted
January 7, 2008
First Posted
January 16, 2008
Study Start
November 1, 2006
Primary Completion
December 1, 2015
Study Completion
December 1, 2015
Last Updated
February 9, 2016
Record last verified: 2016-02